Feed UTI
UT

Universal Technical Institute

UTI · NYSE

$21.47 +3.12% (+$0.65)
1M -3.94%
Market Cap $1.15B
P/E Ratio 33.44x
Div. Yield -
ROE 10.17%

Bulios Fair Price

$12.28

42.8% downside

Current Price

$21.47

Undervalued Fair Value Overvalued

According to Bulios Fair Price, UTI is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
66 /100
Fair
P/E 33.44x
PEG 0.36x
EV/EBITDA 13.16x
Growth
100 /100
Growing
EPS growth 43.80%
Book val. growth 15.06%
Rev. growth 25.90%
Profitability
32 /100
Weak
Gross margin 61.51%
FCF margin 2.59%
Net margin 3.88%
Quality
41 /100
Average
ROIC 4.68%
Asset turnover 0.98x
ROE 10.17%
Debt
61 /100
Moderate
Debt/Equity 1.04x
Net debt/EBITDA 2.19x
Current ratio 1.30x
Stability
39 /100
Moderate
Beta 1.17x
Profitable years 6
Rev. volatility 16.33%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about UTI
Online

Sector

Consumer Defensive

Industry

Education & Training Services

CEO

Jerome A. Grant

Employees

4,100

Headquarters

Phoenix

Upcoming events

18 NOV

Earnings

Upcoming earnings report

59d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.